HALISTER: Novartis Said to Be in Talks to Acquire Amneal Pharmaceuticals

Novartis Said to Be in Talks to Acquire Amneal Pharmaceuticals

(Bloomberg) -- Novartis and Amneal may reach agreement soon, people familiar say.
  • Closely held Amneal may be valued at as much as $8b
  • Amneal is working with an adviser as it explores options, two people said
  • No final decision has been made and sale may still fall apart, people said
  • Novartis spokesman declined to comment
  • Representative for Bridgewater, NJ-based Amneal also declined to comment
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
2341014Z US (Amneal Pharmaceuticals LLC)
NOVN VX (Novartis AG)

To de-activate this alert, click here

UUID: 7947283